174 related articles for article (PubMed ID: 18096760)
1. Characterization of the molecular fragment that is responsible for agonism of pergolide at serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A receptors.
Görnemann T; Hübner H; Gmeiner P; Horowski R; Latté KP; Flieger M; Pertz HH
J Pharmacol Exp Ther; 2008 Mar; 324(3):1136-45. PubMed ID: 18096760
[TBL] [Abstract][Full Text] [Related]
2. The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.
Kekewska A; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2011 Jul; 338(1):381-91. PubMed ID: 21518772
[TBL] [Abstract][Full Text] [Related]
3. Agonism at 5-HT2B receptors is not a class effect of the ergolines.
Jähnichen S; Horowski R; Pertz HH
Eur J Pharmacol; 2005 Apr; 513(3):225-8. PubMed ID: 15862804
[TBL] [Abstract][Full Text] [Related]
4. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
6. Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.
Schurad B; Horowski R; Jähnichen S; Görnemann T; Tack J; Pertz HH
Life Sci; 2006 Apr; 78(20):2358-64. PubMed ID: 16310806
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
8. Endogenous 5-HT2B receptor activation regulates neonatal respiratory activity in vitro.
Günther S; Maroteaux L; Schwarzacher SW
J Neurobiol; 2006 Aug; 66(9):949-61. PubMed ID: 16758492
[TBL] [Abstract][Full Text] [Related]
9. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
[TBL] [Abstract][Full Text] [Related]
10. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
Adams JW; Ramirez J; Shi Y; Thomsen W; Frazer J; Morgan M; Edwards JE; Chen W; Teegarden BR; Xiong Y; Al-Shamma H; Behan DP; Connolly DT
J Pharmacol Exp Ther; 2009 Oct; 331(1):96-103. PubMed ID: 19628629
[TBL] [Abstract][Full Text] [Related]
11. Function and expression differences between ergot and non-ergot dopamine D2 agonists on heart valve interstitial cells.
Oana F; Onozuka H; Tsuchioka A; Suzuki T; Tanaka N; Kaidoh K; Hoyano Y; Hiratochi M; Kikuchi S; Takehana Y; Shibata N
J Heart Valve Dis; 2014 Mar; 23(2):246-52. PubMed ID: 25076559
[TBL] [Abstract][Full Text] [Related]
12. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
Allerton CM; Andrews MD; Blagg J; Ellis D; Evrard E; Green MP; Liu KK; McMurray G; Ralph M; Sanderson V; Ward R; Watson L
Bioorg Med Chem Lett; 2009 Oct; 19(19):5791-5. PubMed ID: 19716297
[TBL] [Abstract][Full Text] [Related]
14. Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.
Kekewska A; Görnemann T; Jantschak F; Glusa E; Pertz HH
J Pharmacol Exp Ther; 2012 Feb; 340(2):369-76. PubMed ID: 22049464
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.
Setola V; Dukat M; Glennon RA; Roth BL
Mol Pharmacol; 2005 Jul; 68(1):20-33. PubMed ID: 15831837
[TBL] [Abstract][Full Text] [Related]
16. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.
Braden MR; Parrish JC; Naylor JC; Nichols DE
Mol Pharmacol; 2006 Dec; 70(6):1956-64. PubMed ID: 17000863
[TBL] [Abstract][Full Text] [Related]
17. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.
Janoshazi A; Deraet M; Callebert J; Setola V; Guenther S; Saubamea B; Manivet P; Launay JM; Maroteaux L
Mol Pharmacol; 2007 Jun; 71(6):1463-74. PubMed ID: 17325130
[TBL] [Abstract][Full Text] [Related]
18. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
19. Pergolide, terguride and N,N'-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery.
Kren V; Eich E; Pertz HH
Physiol Res; 2004; 53(1):35-43. PubMed ID: 14984312
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.
Kelly CR; Sharif NA
J Pharmacol Exp Ther; 2006 Jun; 317(3):1254-61. PubMed ID: 16517693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
